Medical Device | May 20, 2022
Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
Gupta to retire at the end of his current term on May 12, 2022, after more than a decade of service, during which time Avantor has transformed into a global life sciences leader
Autism spectrum disorder affects 78 million people and families worldwide
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
